Rite Aid (RAD): Credit Suisse Gives Up

As Rite Aid (RAD) continues its precipitous decline, Credit Suisse has decided they’ve seen enough. The bank is pulling the plug on their support:

RAD has been an extremely frustrating stock, as the combination of mismanagement and difficult industry conditions have resulted in disappointing sales and earnings over the last few quarters. While the stock is at a 10-year low and liquidity is not a near-term issue, we are increasingly concerned about the company’s ability to manage through the challenging economic/drug retailing landscape, guidance looks aggressive, and the stock is still not cheap. While we are not proud of downgrading the stock at $1.35, keep in mind that it still has a $1.1 billion equity value.

Lehman, meanwhile, still sees the troubled stock more than doubling…to $4.

Credit Suisse downgraded Rite Aid (RAD) from Outperform to NEUTRAL, target price of $2.

See Also:
Rite Aid (RAD) To More Than Double. To $4.

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.